PharmaResearch hosts 5th global symposium on 'Rejuran'

Q: How long will it take to read this news story?

The story "PharmaResearch hosts 5th global symposium on &#039;Rejuran&#039;" has 352 words across 19 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "PharmaResearch hosts 5th global symposium on &#039;Rejuran&#039;" was covered 2 weeks ago by Korea Economic Daily, a news publisher based in South Korea.

Q: How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news. The outlet is headquartered in South Korea and publishes an average of 16 news stories per day. It's most recent story was published 53 minutes ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23386577</li><li>URL: https://beamstart.com/news/pharmaresearch-hosts-5th-global-symposium-17306793</li></ul>

Korea Economic Daily Logo Korea Economic Daily 2w ago

PharmaResearch hosts 5th global symposium on 'Rejuran' - Korea Economic Daily

Quick Summary:

The IRC, composed of domestic and international medical professionals, plans to conduct global research based on Rejuran and DOT™PN.“Rejuran has proven consistent efficacy and safety across various skin types.

Especially with the launch of the IRC, we will activate global research and strive to make Rejuran a globally trusted brand by providing effective solutions tailored to various skin types and conditions,” a PharmaResearch official explained.by Jeong Min Nampeux@hankyung.

Atchima Suwanchinda, a member of the IRC, stated.“It is significant that medical professionals from around the world could engage in in-depth discussions on the clinical efficacy and safety of Rejuran through this symposium.